A Phase 2 Trial to Evaluate the Safety and Efficacy of UB-621
Clinical trial NCT03595995 · UNKNOWN
Trial details
- NCT number
- NCT03595995
- Sponsor
- United BioPharma
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2024-06-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.